These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 23789377)
21. [Sexual disorders in patients with prostatic adenoma combined with chronic prostatitis and without]. Iunda IF; Varvashenia VV Lik Sprava; 1993; (10-12):47-51. PubMed ID: 7518169 [TBL] [Abstract][Full Text] [Related]
22. [Changes in microcirculation of the urinary bladder in patients with stage II prostatic adenoma depending on the treatment method]. Pavlov VN; Kazikhinurov AA; Ishemgulov RR; Mustafin AT Urologiia; 2008; (1):31-2, 34-5. PubMed ID: 18649676 [TBL] [Abstract][Full Text] [Related]
23. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study. Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612 [TBL] [Abstract][Full Text] [Related]
24. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate. Oka M; Ueda M; Oyama T; Kyotani J; Tanaka M Prostate; 2009 Sep; 69(13):1404-10. PubMed ID: 19489033 [TBL] [Abstract][Full Text] [Related]
25. [Treatment of elderly and senile patients suffering from benign prostatic hyperplasia and chronic prostatitis]. Miakotnykh VS; Tret'iakov VV; Borovkova TA Adv Gerontol; 2013; 26(4):689-95. PubMed ID: 24738261 [TBL] [Abstract][Full Text] [Related]
26. [Experience in vitaprost treatment of patients with chronic abacterial prostatitis and prostatic adenoma after prostatic arteries embolism]. Iakovets IaV; Iakovets EA; Neĭmark AI; Karpenko AA; Arzamastsev DD Urologiia; 2011; (5):33-4, 36-9. PubMed ID: 22279784 [TBL] [Abstract][Full Text] [Related]
27. [Urological and sexual evaluation of treatment of benign prostatic disease using Pygeum africanum at high doses]. Carani C; Salvioli V; Scuteri A; Borelli A; Baldini A; Granata AR; Marrama P Arch Ital Urol Nefrol Androl; 1991 Sep; 63(3):341-5. PubMed ID: 1723220 [TBL] [Abstract][Full Text] [Related]
28. [A comparative clinical randomized trial of cernilton efficacy and safety in patients with chronic abacterial prostatitis]. Apolikhin OI; Aliaev IuG; Sivkov AV; Vinarov AZ; Oshchepkov VN; Keshishev NG; Bedretdinova DA; Akhvlediani ND Urologiia; 2010; (1):29-34. PubMed ID: 20891044 [TBL] [Abstract][Full Text] [Related]
29. [The relationship of postoperative thrombotic-hemorrhagic complications to the local acute inflammatory process in patients with prostatic adenoma]. Shabad AL; Rumiantsev VB; Kudriavtsev IuV Urol Nefrol (Mosk); 1995; (2):30-3. PubMed ID: 7540339 [TBL] [Abstract][Full Text] [Related]
30. [Efficacy of natural therapeutic factors of Belokurikha health resort in rehabilitation of patients with chronic prostatitis]. Neĭmark AI; Bondarev EN Urologiia; 2005; (5):53-6. PubMed ID: 16281842 [TBL] [Abstract][Full Text] [Related]
32. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate. van Vuuren SP; Heyns CF; Zarrabi AD BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551 [TBL] [Abstract][Full Text] [Related]
33. [Clinicopathophysiological aspects of utilization of local physiotherapy device mavit in combined treatment of patients with chronic prostatitis and symptomatic prostatic adenoma]. Zhiborev BN; Zhiborev AB; Rakcheev BIu Urologiia; 2011; (6):36, 38-42. PubMed ID: 22448479 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia. Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042 [TBL] [Abstract][Full Text] [Related]
35. [The joint use of hyperbaric oxygenation and EHF therapy in benign prostatic hyperplasia and its combination with chronic prostatitis]. Loran OB; Dunaevskiĭ IaL; Vishnevskiĭ AE; Vashkevich VI Urol Nefrol (Mosk); 1997; (2):32-4. PubMed ID: 9206881 [TBL] [Abstract][Full Text] [Related]
36. [Clinical effect of the drug "Prostamol-Uno" in patients with benign prostatic hyperplasia and chronic prostatitis]. Mazo EB; Dmitriev DG Urologiia; 2001; (5):38-41. PubMed ID: 11641979 [No Abstract] [Full Text] [Related]
37. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis]. Wu XJ; Yang LY; Zhang XZ Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of Prostant on chronic prostatitis in 119 patients. Xu G; Zhang YF; Ding Q Acta Pharmacol Sin; 2003 Jun; 24(6):615-8. PubMed ID: 12791192 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of clarithromycin in the prostate: implications for the treatment of chronic abacterial prostatitis. Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Panou C; Adamakis I; Giamarellou H J Urol; 2001 Jan; 165(1):97-9. PubMed ID: 11125373 [TBL] [Abstract][Full Text] [Related]
40. [The preoperative anti-inflammatory and postoperative therapy of patients with calculous pyelonephritis and prostatic adenoma with chronic prostatitis under outpatient polyclinic conditions]. Shabad AL; Minakov NK; Mkrtchan GG; Zabirov KI Urol Nefrol (Mosk); 1994; (5):24-7. PubMed ID: 7532881 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]